SSA
ACET icon

Schonfeld Strategic Advisors’s Adicet Bio ACET Stock Holding History

Schonfeld Strategic Advisors’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-29,944
Closed -$388K – 1994
2025
Q3 		$388K Sell
29,944
-87,562
-75% -$1.03M ﹤0.01% 1762
2025
Q2 		$1.15M Buy
+117,506
New +$1.24M 0.01% 1245
2024
Q3 		– Sell
-1,850
Closed -$35.8K – 1994
2024
Q2 		$35.8K Sell
1,850
-69,050
-97% -$1.85M ﹤0.01% 1966
2024
Q1 		$2.67M Buy
70,900
+58,394
+467% +$2.42M 0.02% 892
2023
Q4 		$378K Buy
+12,506
New +$273K ﹤0.01% 1366
2023
Q3 		– Sell
-1,081
Closed -$42K – 1719
2023
Q2 		$42K Buy
+1,081
New +$95.4K ﹤0.01% 1831

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Schonfeld Strategic Advisors's ACET Position: Q4 2025 in Review

Schonfeld Strategic Advisors sold out of Adicet Bio (ACET) in Q4 2025, closing a stake of 29,944 shares — an estimated $388K sold.

Schonfeld Strategic Advisors first reported a position in ACET in Q2 2023 and held it in 6 quarters. The position peaked at $2.67M in Q1 2024. 49 funds tracked by Wall St. Rank hold ACET as of Q4 2025.

  • Schonfeld Strategic Advisors reported no remaining Adicet Bio position as of Q4 2025 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 29,944 Adicet Bio shares in Q4 2025, an estimated $388K.
  • Schonfeld Strategic Advisors first reported a position in Adicet Bio in Q2 2023 and held it in 6 quarters.
  • Schonfeld Strategic Advisors's Adicet Bio position peaked at $2.67M in Q1 2024.
  • 49 funds tracked by Wall St. Rank held Adicet Bio as of Q4 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.